X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
cancer (6) 6
humans (6) 6
oncology (6) 6
pharmacology & pharmacy (6) 6
breast-cancer (4) 4
antineoplastic agents - adverse effects (3) 3
breast cancer (3) 3
cardiotoxicity (3) 3
chemotherapy (3) 3
ejection fraction (3) 3
heart-failure (3) 3
hematology (3) 3
neoplasms - drug therapy (3) 3
quality of life (3) 3
zoledronic acid (3) 3
antineoplastic agents - administration & dosage (2) 2
antitumor drugs (2) 2
bnp (2) 2
bone metastases (2) 2
bone neoplasms - secondary (2) 2
breast neoplasms - pathology (2) 2
cancer patients (2) 2
care and treatment (2) 2
cell lung-cancer (2) 2
diastolic dysfunction (2) 2
double-blind (2) 2
female (2) 2
health aspects (2) 2
nt-probnp (2) 2
phase-iii trial (2) 2
prostate cancer (2) 2
risk (2) 2
risk factors (2) 2
toxicity (2) 2
tyrosine kinase inhibitors (2) 2
1st-line treatment (1) 1
adenosyl-l-methionine (1) 1
adult (1) 1
advanced breast-cancer (1) 1
advanced solid tumors (1) 1
aflibercept (1) 1
aflibercept; bevacizumab; bisphosphonate; bisphosphonate-related osteonecrosis of the jaw; denosumab; everolimus; medication-related osteonecrosis of the jaw (1) 1
age (1) 1
aged (1) 1
american association (1) 1
american-society (1) 1
analgesics (1) 1
analgesics, opioid - pharmacology (1) 1
analgesics, opioid - therapeutic use (1) 1
analysis (1) 1
anatomy and physiology (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
anthracycline cardiotoxicity (1) 1
anthracyclines (1) 1
antianginal agent (1) 1
antibody therapy (1) 1
anticancer agents (1) 1
anticancer section / original paper (1) 1
atrial myocardium (1) 1
basic cancer research (1) 1
bevacizumab (1) 1
biocompatibility (1) 1
biologic agents (1) 1
biological therapy - adverse effects (1) 1
biology (1) 1
biomarkers (1) 1
biomedical materials (1) 1
bisphosphonate (1) 1
bisphosphonate-associated osteonecrosis of the jaw - diagnosis (1) 1
bisphosphonate-associated osteonecrosis of the jaw - etiology (1) 1
bisphosphonate-associated osteonecrosis of the jaw - pathology (1) 1
bisphosphonate-related osteonecrosis (1) 1
bisphosphonate-related osteonecrosis of the jaw (1) 1
bisphosphonates (1) 1
body mass index (1) 1
bone (1) 1
bone and soft tissue sarcomas (1) 1
bone cancer (1) 1
bone density (1) 1
bone growth (1) 1
bone neoplasms - physiopathology (1) 1
bone remodelling (1) 1
bone tumors (1) 1
breast (1) 1
breast cancer, bone metastasis, rank-rankl (1) 1
breast neoplasms - metabolism (1) 1
breast tumors (1) 1
cancer pain (1) 1
cancer pain - drug therapy (1) 1
cancer survivors (1) 1
cancer treatment (1) 1
cancer-patients (1) 1
cancers and neoplasms (1) 1
carcinoma (1) 1
carcinoma, ovarian epithelial (1) 1
cardiac dysfunction (1) 1
cell migration (1) 1
chemical and drug induced liver injury - diagnosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 05/2011, Volume 6, Issue 4, p. e19234
Journal Article
Oncology, ISSN 0030-2414, 06/2018, Volume 95, Issue 1, pp. 1 - 7
Objectives: Low body mass index (BMI) and/or low lean body mass have been shown to be risk factors for chemotherapy-related toxicities in a number of different... 
Clinical Study | Body mass index | Sarcopenia | Trabectedin | Toxicity | Soft-tissue sarcoma | Neutropenia | TREATMENT OUTCOMES | DETERMINANT | CANCER | WOMEN | OBESITY | IMPACT | THERAPY | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | NUTRITIONAL-STATUS | Chemotherapy | Anthracyclines | Sarcoma | Risk factors | Cancer | Index Medicus
Journal Article
Expert Opinion on Drug Safety, ISSN 1474-0338, 07/2016, Volume 15, Issue 7, pp. 925 - 935
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e22517 - e22517
Journal Article
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, ISSN 0022-3565, 08/2019, Volume 370, Issue 2, pp. 197 - 205
We have reported that anthracyclines and nonanthracycline chemotherapeutics caused diastolic dysfunction in cancer patients without cardiovascular risk... 
RECOMMENDATIONS | EJECTION FRACTION | HEART-FAILURE | CARDIAC DYSFUNCTION | ANTIANGINAL AGENT | ISCHEMIA | CARDIOTOXICITY | PHARMACOLOGY & PHARMACY | NATRIURETIC PEPTIDE | SURVIVORS | AMERICAN-SOCIETY
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 07/2018, Volume 366, Issue 1, pp. 158 - 168
B-type natriuretic peptide (BNP) is widely used as a diagnostic marker of systolic dysfunction. We previously conducted a clinical study in which anthracycline... 
ATRIAL MYOCARDIUM | BNP | EJECTION FRACTION | HEART-FAILURE | CARDIOTOXICITY | PHARMACOLOGY & PHARMACY | TERMINAL PROBNP | SINOATRIAL NODE | ANTITUMOR DRUGS | ELECTRICAL-CONDUCTION | NT-PROBNP
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 04/2018, Volume 124, pp. 51 - 60
Journal Article
Conference Proceeding
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.